Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04606069
What this trial is testing

Treat COVID-19 Patients With Regadenoson

Who this might be right for
COVID-19Lung Inflammation
University of Maryland, Baltimore 5
Testing effectiveness (Phase 2)Study completedNCT04343768
What this trial is testing

An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 60
Not applicableWithdrawnNCT04651387
What this trial is testing

Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients

Who this might be right for
SARS-CoV Infection
Neuromed IRCCS
Large-scale testing (Phase 3)Temporarily pausedNCT04341870
What this trial is testing

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

Who this might be right for
COVID19SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 27
Not applicableStudy completedNCT04667923
What this trial is testing

Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome

Who this might be right for
Covid19ARDS
I.M. Sechenov First Moscow State Medical University 80
Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Large-scale testing (Phase 3)Study completedNCT04374032
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Infection
Bosnalijek D.D 120
Testing effectiveness (Phase 2)Temporarily pausedNCT04711863
What this trial is testing

Fluvoxamine for Adults With Mild to Moderate COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Coronavirus InfectionMild to Moderate COVID-19
Asan Medical Center 400
Testing effectiveness (Phase 2)Study completedNCT04363736
What this trial is testing

Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 97
Large-scale testing (Phase 3)Study completedNCT04732949
What this trial is testing

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2COVID-19
Synairgen Research Ltd. 623
Early research (Phase 1)WithdrawnNCT04490486
What this trial is testing

Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeCorona Virus Infection
Joshua M Hare
Testing effectiveness (Phase 2)Study completedNCT04357808
What this trial is testing

Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID)

Who this might be right for
Covid-19
Maria del Rosario Garcia de Vicuña Pinedo 30
Large-scale testing (Phase 3)Study completedNCT05999435
What this trial is testing

Study of LAU-7b for the Treatment of Long COVID in Adults

Who this might be right for
Long COVID
Laurent Pharmaceuticals Inc. 272
Early research (Phase 1)Ended earlyNCT05386472
What this trial is testing

Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

Who this might be right for
COVID-19
Pfizer 25
Not applicableWithdrawnNCT04953312
What this trial is testing

Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)

Who this might be right for
Severe/Moderate CoronavirusChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes+1 more
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)WithdrawnNCT04355676
What this trial is testing

Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19

Who this might be right for
Coronavirus Infection
Karyopharm Therapeutics Inc
Testing effectiveness (Phase 2)Study completedNCT04707664
What this trial is testing

Sargramostim Use in COVID-19 to Recover Patient Health

Who this might be right for
Covid19SARS-CoV Infection
Partner Therapeutics, Inc. 600
Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200
Large-scale testing (Phase 3)Ended earlyNCT04516811
What this trial is testing

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV-2 InfectionSevere Acute Respiratory Syndrome Coronavirus 2
South African National Blood Service 102
Large-scale testing (Phase 3)Ended earlyNCT04928430
What this trial is testing

Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19

Who this might be right for
COVID-19
Xenothera SAS 290
Next Page